You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ABBV-951

Showing 101 - 121 of 121
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Cancer Trial in United States (SC-003, SC-003 in combination with ABBV-181)

Terminated
  • Ovarian Cancer
  • SC-003
  • SC-003 in combination with ABBV-181
  • Fayetteville, Arkansas
  • +15 more
Jan 2, 2019

Crohn Disease Trial (risankizumab IV, risankizumab SC, Placebo)

Completed
Has Results
  • Crohn Disease
  • risankizumab IV
  • +2 more
  • (no location specified)
Oct 25, 2018

Advanced Solid Tumors Cancer Trial in Worldwide (ABBV-176)

Terminated
  • Advanced Solid Tumors Cancer
  • Scottsdale, Arizona
  • +10 more
Nov 28, 2018

Multiple Myeloma Trial in Worldwide (ABBV-838, Pomalidomide, Dexamethasone)

Terminated
  • Multiple Myeloma
  • Chicago, Illinois
  • +18 more
Sep 12, 2018

Head and Neck Squamous Cell Carcinoma, NSCLC, Triple Negative Breast Cancer Trial in Boston, San Antonio, Madrid (ABBV-221)

Terminated
  • Head and Neck Squamous Cell Carcinoma
  • +4 more
  • Boston, Massachusetts
  • +4 more
Mar 28, 2018

Psoriasis Trial in United States (ABBV-553, Placebo)

Terminated
  • Psoriasis
  • Anaheim, California
  • +3 more
Nov 2, 2017

Healthy Trial in Tokyo, Sumida-ku, Busan (ABBV-066, Placebo)

Completed
  • Healthy
  • Tokyo, Sumida-ku, Japan
  • +1 more
Jul 5, 2017

Multiple Myeloma Trial in Darlinghurst, Fitzroy, Prahran (Venetoclax, ABBV-838, Dexamethasone)

Withdrawn
  • Multiple Myeloma
  • Darlinghurst, Australia
  • +2 more
Jun 1, 2017

Gastrointestinal Cancer Trial in Boston (Everolimus, Tivozanib)

Completed
Has Results
  • Gastrointestinal Cancer
  • Boston, Massachusetts
  • +2 more
Apr 11, 2017

Anemia of Chronic Kidney Disease Trial in Minneapolis (JTZ-951, 14C-JTZ-951)

Completed
  • Anemia of Chronic Kidney Disease
  • JTZ-951, 14C-JTZ-951
  • Minneapolis, Minnesota
    (unnamed)
Nov 28, 2016

NSCLC Trial (AMG 951 (rhApo2L/TRAIL), Bevacizumab, Carboplatin)

Completed
  • Non-Small Cell Lung Cancer
  • AMG 951 (rhApo2L/TRAIL)
  • +3 more
  • (no location specified)
Jun 10, 2016

Anemia of Chronic Kidney Disease Trial in Minneapolis (JTZ-951, Lapatinib)

Completed
  • Anemia of Chronic Kidney Disease
  • Minneapolis, Minnesota
    (unnamed)
Apr 27, 2016

Rheumatoid Arthritis Trial in Berlin (ABBV-257, Placebo)

Completed
  • Rheumatoid Arthritis
  • ABBV-257
  • Placebo
  • Berlin, Germany
    Site Reference ID/Investigator# 139394
Mar 1, 2016

Anemia of Chronic Kidney Disease Trial in United States (JTZ-951, Placebo)

Completed
  • Anemia of Chronic Kidney Disease
  • Lakewood, Colorado
  • +4 more
Jul 11, 2014

Anemia in Chronic Kidney Disease Trial in Minneapolis (JTZ-951)

Completed
  • Anemia in Chronic Kidney Disease
  • Minneapolis, Minnesota
    (unnamed)
Mar 15, 2014

Advanced Solid Tumors, Locally Advanced or Metastatic Breast or Colorectal Cancer Trial in Scottsdale, Fort Myers, Nashville

Completed
  • Advanced Solid Tumors
  • Locally Advanced or Metastatic Breast or Colorectal Cancer
  • tivozanib (AV-951) and capecitabine (Xeloda®)
  • Scottsdale, Arizona
  • +2 more
Jan 23, 2014

Colorectal Cancer, Gastrointestinal Cancer Trial in Groningen, Rotterdam (Tivozanib (AV-951) plus FOLFOX6)

Completed
  • Colorectal Cancer
  • Gastrointestinal Cancer
  • Tivozanib (AV-951) plus FOLFOX6
  • Groningen, Netherlands
  • +1 more
Aug 24, 2012

NSCLC Trial in Washington, Kansas City, New York (Tivozanib (AV-951))

Completed
  • Carcinoma, Non-Small-Cell Lung
  • Tivozanib (AV-951)
  • Washington, District of Columbia
  • +2 more
Jun 27, 2012

Metastatic Breast Cancer Trial in Boston, New York, Essen (tivozanib (AV-951) + paclitaxel)

Completed
  • Metastatic Breast Cancer
  • tivozanib (AV-951) + paclitaxel
  • Boston, Massachusetts
  • +2 more
Jun 27, 2012

Food Effect of Tivozanib in Health Subjects Trial in Dallas (tivozanib)

Completed
  • Food Effect of Tivozanib in Health Subjects
  • Dallas, Texas
    Covance Clinical Research Unit, Inc.
Jun 1, 2012

Renal Cell Carcinoma Trial in United States (tivozanib (AV-951) plus temsirolimus)

Completed
  • Renal Cell Carcinoma
  • tivozanib (AV-951) plus temsirolimus
  • Los Angeles, California
  • +4 more
Sep 30, 2011